RaySearch Laboratories AB (publ)

$24.63+0.00%(+$0.00)
TickerSpark Score
70/100
Solid
53
Valuation
95
Profitability
80
Growth
92
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RSLBF research report →

52-Week Range28% of range
Low $19.57
Current $24.63
High $37.36

Companywww.raysearchlabs.com

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities.

CEO
Johan Lof
IPO
2015
Employees
416
HQ
Stockholm, SE

Price Chart

-23.49% · this period
$37.36$28.46$19.57May 16Nov 14May 18

Valuation

Market Cap
$844.21M
P/E
31.17
P/S
5.36
P/B
6.70
EV/EBITDA
16.29
Div Yield
1.96%

Profitability

Gross Margin
81.36%
Op Margin
21.58%
Net Margin
17.21%
ROE
23.62%
ROIC
14.35%

Growth & Income

Revenue
$1.34B · 12.77%
Net Income
$227.80M · 11.93%
EPS
$6.65 · 11.95%
Op Income
$292.30M
FCF YoY
-40.64%

Performance & Tape

52W High
$37.36
52W Low
$19.57
50D MA
$25.46
200D MA
$28.72
Beta
0.93
Avg Volume
14

Get TickerSpark's AI analysis on RSLBF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our RSLBF Coverage

We haven't published any research on RSLBF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate RSLBF Report →

Similar Companies